These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34805637)

  • 1. Cost-Effectiveness of Targeted Exome Analysis as a Diagnostic Test in Glomerular Diseases.
    Jayasinghe K; Wu Y; Stark Z; Kerr PG; Mallett AJ; Gaff C; Martyn M; Goranitis I; Quinlan C
    Kidney Int Rep; 2021 Nov; 6(11):2850-2861. PubMed ID: 34805637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic testing for suspected monogenic kidney disease in children and adults: A health economic evaluation.
    Wu Y; Jayasinghe K; Stark Z; Quinlan C; Patel C; McCarthy H; Mallawaarachchi AC; Kerr PG; Alexander S; Mallett AJ; Goranitis I;
    Genet Med; 2023 Nov; 25(11):100942. PubMed ID: 37489581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions.
    Tan TY; Dillon OJ; Stark Z; Schofield D; Alam K; Shrestha R; Chong B; Phelan D; Brett GR; Creed E; Jarmolowicz A; Yap P; Walsh M; Downie L; Amor DJ; Savarirayan R; McGillivray G; Yeung A; Peters H; Robertson SJ; Robinson AJ; Macciocca I; Sadedin S; Bell K; Oshlack A; Georgeson P; Thorne N; Gaff C; White SM
    JAMA Pediatr; 2017 Sep; 171(9):855-862. PubMed ID: 28759686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions.
    Lavelle TA; Feng X; Keisler M; Cohen JT; Neumann PJ; Prichard D; Schroeder BE; Salyakina D; Espinal PS; Weidner SB; Maron JL
    Genet Med; 2022 Jun; 24(6):1349-1361. PubMed ID: 35396982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(11):1-178. PubMed ID: 32194879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management, and reproductive outcomes.
    Schofield D; Rynehart L; Shresthra R; White SM; Stark Z
    Genet Med; 2019 Nov; 21(11):2586-2593. PubMed ID: 31110331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement.
    Stark Z; Schofield D; Alam K; Wilson W; Mupfeki N; Macciocca I; Shrestha R; White SM; Gaff C
    Genet Med; 2017 Aug; 19(8):867-874. PubMed ID: 28125081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of Exome Sequencing versus Targeted Gene Panels for Prenatal Diagnosis of Fetal Effusions and Non-Immune Hydrops Fetalis.
    Avram CM; Caughey AB; Norton ME; Sparks TN
    Am J Obstet Gynecol MFM; 2022 Nov; 4(6):100724. PubMed ID: 35995366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome Sequencing for Isolated Congenital Hearing Loss: A Cost-Effectiveness Analysis.
    Downie L; Amor DJ; Halliday J; Lewis S; Martyn M; Goranitis I
    Laryngoscope; 2021 Jul; 131(7):E2371-E2377. PubMed ID: 33382469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome Sequencing for Prenatal Detection of Genetic Abnormalities in Fetal Ultrasound Anomalies: An Economic Evaluation.
    Kodabuckus SS; Quinlan-Jones E; McMullan DJ; Maher ER; Hurles ME; Barton PM; Kilby MD
    Fetal Diagn Ther; 2020; 47(7):554-564. PubMed ID: 31962312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectiveness.
    Palmer EE; Schofield D; Shrestha R; Kandula T; Macintosh R; Lawson JA; Andrews I; Sampaio H; Johnson AM; Farrar MA; Cardamone M; Mowat D; Elakis G; Lo W; Zhu Y; Ying K; Morris P; Tao J; Dias KR; Buckley M; Dinger ME; Cowley MJ; Roscioli T; Kirk EP; Bye A; Sachdev RK
    Mol Genet Genomic Med; 2018 Mar; 6(2):186-199. PubMed ID: 29314763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: Evidence from Canada.
    Regier DA; Loewen R; Chan B; Ehman M; Pollard S; Friedman JM; Stockler-Ipsiroglu S; van Karnebeek C; Race S; Elliott AM; Dragojlovic N; Lynd LD; Weymann D
    Genet Med; 2024 Apr; 26(4):101069. PubMed ID: 38205742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the clinical utility of early exome sequencing in diverse pediatric outpatient populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 study: a randomized controlled trial.
    Staley BS; Milko LV; Waltz M; Griesemer I; Mollison L; Grant TL; Farnan L; Roche M; Navas A; Lightfoot A; Foreman AKM; O'Daniel JM; O'Neill SC; Lin FC; Roman TS; Brandt A; Powell BC; Rini C; Berg JS; Bensen JT
    Trials; 2021 Jun; 22(1):395. PubMed ID: 34127041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimising Exome Prenatal Sequencing Services (EXPRESS): a study protocol to evaluate rapid prenatal exome sequencing in the NHS Genomic Medicine Service.
    Hill M; Ellard S; Fisher J; Fulop N; Knight M; Kroese M; Ledger J; Leeson-Beevers K; McEwan A; McMullan D; Mellis R; Morris S; Parker M; Tapon D; Baple E; Blackburn L; Choudry A; Lafarge C; McInnes-Dean H; Peter M; Ramakrishnan R; Roberts L; Searle B; Smith E; Walton H; Wynn SL; Han Wu W; Chitty LS
    NIHR Open Res; 2022; 2():10. PubMed ID: 35935673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of genomic testing in patients with suspected monogenic kidney disease.
    Jayasinghe K; Stark Z; Kerr PG; Gaff C; Martyn M; Whitlam J; Creighton B; Donaldson E; Hunter M; Jarmolowicz A; Johnstone L; Krzesinski E; Lunke S; Lynch E; Nicholls K; Patel C; Prawer Y; Ryan J; See EJ; Talbot A; Trainer A; Tytherleigh R; Valente G; Wallis M; Wardrop L; West KH; White SM; Wilkins E; Mallett AJ; Quinlan C
    Genet Med; 2021 Jan; 23(1):183-191. PubMed ID: 32939031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of Genome and Exome Sequencing in Children Diagnosed with Autism Spectrum Disorder.
    Yuen T; Carter MT; Szatmari P; Ungar WJ
    Appl Health Econ Health Policy; 2018 Aug; 16(4):481-493. PubMed ID: 29651777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2022; 22(3):1-155. PubMed ID: 36158868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost and diagnostic yield of exome sequencing for children with suspected genetic disorders: a benchmarking study.
    Dragojlovic N; Elliott AM; Adam S; van Karnebeek C; Lehman A; Mwenifumbo JC; Nelson TN; du Souich C; Friedman JM; Lynd LD
    Genet Med; 2018 Sep; 20(9):1013-1021. PubMed ID: 29300375
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.